Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Margolin

Showing results (381-390 of 406) with videos related to

Pageof 41
Sort By:
Neuro-Oncology|April 21, 2021
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)Hussein A Tawbi, Peter A Forsyth, F Stephen Hodi, et al.
The Lancet. Oncology|November 14, 2021
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 studyHussein A Tawbi, Peter A Forsyth, F Stephen Hodi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Annals of Surgery|August 7, 2018
Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled TrialJames Fleshman, Megan E Branda, Daniel J Sargent, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 16, 2011
Kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
Testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinomaDavid F McDermott, Su-Chun Cheng, Sabina Signoretti, et al.
Science Translational Medicine|April 19, 2013
Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancerAdam A Margolin, Erhan Bilal, Erich Huang, et al.
Journal for Immunotherapy of Cancer|June 1, 2018
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0Ryan J Sullivan, Michael B Atkins, John M Kirkwood, et al.
Pageof 41

Showing results (381-390 of 406) with videos related to

Sort By:
Pageof 41
Neuro-Oncology|April 21, 2021
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)Hussein A Tawbi, Peter A Forsyth, F Stephen Hodi, et al.
The Lancet. Oncology|November 14, 2021
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 studyHussein A Tawbi, Peter A Forsyth, F Stephen Hodi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Annals of Surgery|August 7, 2018
Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled TrialJames Fleshman, Megan E Branda, Daniel J Sargent, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 16, 2011
Kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
Testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinomaDavid F McDermott, Su-Chun Cheng, Sabina Signoretti, et al.
Science Translational Medicine|April 19, 2013
Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancerAdam A Margolin, Erhan Bilal, Erich Huang, et al.
Journal for Immunotherapy of Cancer|June 1, 2018
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0Ryan J Sullivan, Michael B Atkins, John M Kirkwood, et al.
Pageof 41